The impact of British and US guidelines for initiating combination antiretroviral therapy on estimating national treatment requirements for HIV-positive patients

References

• ALLARDICE , G.M. , MCMENAMIN , J.J. and PARPIA , T. 1998 . The recent impact of anti-retroviral combination therapy on CD4 count in HIV infected persons: as shown by routine HIV surveillance in Scotland . International Journal of STD and AIDS , 9 : 561 – 566 .
   PubMed Web of Science ®Google Scholar
• ANDERSON , J. , ARMSTEAD , R. BAKER , A.C. 1998 . Guidelines for the use of anti-retroviral agents in HIV-infected adults and adolescents . Annals of Internal Medicine , 128 (12 Pt2 SS) : 1079 – 1100 .
   PubMed Web of Science ®Google Scholar
• BARTLETT , J.G. and MOORE , R.D. 1998 . Improving HIV therapy . Scientific American , July : 64 – 73 .
   Web of Science ®Google Scholar
• BELLIS , M.A. , MCCULLAGH , J. , THOMSON , R. , REGAN , D. , SYED , Q. and KELLY , T. 1997 . Inequality in funding for AIDS across England threatens regional services . British Medical Journal , 315 : 950 – 951 .
   PubMedGoogle Scholar
• BHIVA GUIDELINES CO-ORDINATING COMMITTEE . 1997 . British HIV Association guidelines for anti-retroviral treatment of HIV seropositive individuals . Lancet , 349 : 1086 – 1092 .
   PubMed Web of Science ®Google Scholar
• BOWDEN , R.J. and TURKINGTON , D.A. 1984 . Instrumental variables , London : Cambridge University Press .
   Google Scholar
• BUCHBINDER , S.P. , KATZ , M.H. , HESSOL , N.A. , O'MALLEY , P.M. and HOLMBERG , S.D. 1994 . Long term HIV-I infection without immunological progression . AIDS , 8 : 1123 – 1128 .
   PubMed Web of Science ®Google Scholar
• CAESAR CO-ORDINATING COMMITTEE . 1997 . Randomised trial of addition of lamivudine or lamivudine plus loviride to zidovudine-containing regimens for patients with HIV-1 infection: the CAESAR trial . Lancet , 349 : 1413 – 1421 .
   PubMed Web of Science ®Google Scholar
• CARPENTER , C.J. , FISCHL , M.A. , HAMMER , S.M. FOR THE INTERNATIONAL AIDS SOCIETY, USA . 1997 . Antiretroviral therapy for HIV Infection in 1997: updated recommendations of the International AIDS Society, USA panel . Journal of the American Medical Association , 277 : 1962 – 1969 .
   PubMed Web of Science ®Google Scholar
• CARPENTER , C.J. , FISCHL , M.A. , HAMMER , S.M. FOR THE INTERNATIONAL AIDS SOCIETY, USA . 1998 . Antiretroviral therapy for HIV Infection in 1998: updated recommendations of the International AIDS Society, USA panel . Journal of the American Medical Association , 280 : 78 – 86 .
   PubMed Web of Science ®Google Scholar
• CD4 COLLABORATIVE GROUP . 1997 . CD4 surveillance in Scotland: perspectives on severe HIV-related immunodeficiency . AIDS , 11 : 1509 – 1517 .
   PubMed Web of Science ®Google Scholar
• DELTA CO-ORDINATING COMMITTEE . 1996 . Delta: a randomised double blind controlled trial comparing combinations of zidovudine plus didanosine or zalcitabine with zidovudine alone in HIV-infected individuals . Lancet , 348 : 283 – 291 .
   PubMed Web of Science ®Google Scholar
• DIGGLE , P.J. , LIANG , K.Y. and ZEGER , S.L. 1994 . Analysis of longitudinal data , Oxford : Oxford University Press .
   Google Scholar
• EASTERBROOK , P.J. 1994 . Non-progression in HIV infection . AIDS , 8 : 1179 – 1182 .
   PubMed Web of Science ®Google Scholar
• GARCIA , F. , VIDAL , C. , GATELL , J.M. , MIRO , J.M. , SORIANO , A. and PUMAROLA , T. 1997 . Viral load in asymptomatic patients with CD4[sup +] lymphocyte counts above 500 x 10[sup 6]/l . AIDS , II : 53 – 57 .
   Google Scholar
• HAMMER , S.M. , KATZENSTENI , D.A. HUGHES , M.D. 1996 . A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200-500 per cubic millimetre . New England Journal of Medicine , 335 : 1081 – 1090 .
   PubMed Web of Science ®Google Scholar
• HOOVER , D.R. , GRAHAM , N.M.H. CHEN , B. 1992 . Effect of CD4[sup +] cell count measurement variability on staging HIV-1 infection . Journal of AIDS , 5 : 794 – 802 .
   PubMed Web of Science ®Google Scholar
• HUGHES , M.D. , JOHNSON , V.A. HIRSCH , M.S. 1996 . Monitoring plasma HIV-1 RNA levels in addition to CD4[sup +] lymphocyte count improves assessment of anti-retroviral therapeutic response . Annals of Internal Medicine , 126 : 929 – 938 .
   Web of Science ®Google Scholar
• LOVEDAY , C. and HILL , A. 1995 . Prediction of progression to AIDS with serum HIV-1 RNA and CD4 count [letter] . Lancet , 345 : 790 – 791 .
   PubMed Web of Science ®Google Scholar
• MELLORS , J.W. , MUNOZ , A. GIORGI , J.V. 1997 . Plasma viral load and CD4[sup +] lymphocytes as prognostic markers of HIV-1 infection . Annals of Internal Medicine , 126 : 946 – 954 .
   PubMed Web of Science ®Google Scholar
• PARPIA , T. , RAAB , G.M. , ALLARDICE , G.M. , GOLDBERG , D.J. and MCMENAMIN , J.J. 1998 . Modelling HIV disease progression in Scotland using population-based immunological data , Applied Statistics Technical Report, 5 Napier University .
   Google Scholar
• PHILLIPS , A.N. , ERON , J.J. BARTLETT , J.A. 1996 . HIV-1 RNA levels and the development of clinical disease . AIDS , 10 : 859 – 865 .
   PubMed Web of Science ®Google Scholar
• SCOTTISH CENTRE FOR INFECTION AND ENVIRONMENTAL HEALTH . 1995 . HIV and AIDS surveillance in Scotland: review of the epidemic to December 1994 . ANSWER (AIDS News Supplement to the Weekly Report) , 54 December
   Google Scholar
• SCOTTISH HIV AND AIDS GROUP (SHIVAG) . 1998 . “ Draft Scottish HIV Treatment Protocol ” . Scottish Office . Convened by the
   Google Scholar
• STAZEWSKI , S. , HILL , A.M. BARTLETT , J. 1997 . Reductions in HIV-1 disease progression for ZDV/3TC relative to control treatments: a meta-analysis of controlled trials . AIDS , 11 : 477 – 483 .
   PubMed Web of Science ®Google Scholar
• TAYLOR , J.M.G. , FAHEY , J.L. , DETELS , R. and GIORGI , J.V. 1990 . CD4 Percentage, CD4 number, and CD4:CD8 ratio in HIV infection: which to choose and how to use . Journal of AIDS , 3 : 144 – 151 .
   PubMedGoogle Scholar